成大生物 (688739.SH)
27.58 +0.15(0.550%)
+ 收藏
今开:27.48 最高:27.79 成交量:2.63万手
昨收:27.43 最低:27.33 成交额:7236.31万
利润表(成大生物)
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
一、营业总收入(元) | 1,302,689,599.82 | 880,692,770.15 | 364,709,258.37 | 1,750,103,088.24 | 1,334,694,071.78 | 871,308,922.37 | 353,522,532.16 |
营业收入(元) | 1,302,689,599.82 | 880,692,770.15 | 364,709,258.37 | 1,750,103,088.24 | 1,334,694,071.78 | 871,308,922.37 | 353,522,532.16 |
二、营业总成本(元) | 872,113,905.30 | 585,937,644.97 | 257,814,176.43 | 1,103,923,313.70 | 764,513,158.97 | 474,257,967.35 | 212,419,296.10 |
营业成本(元) | 222,550,389.80 | 151,290,019.10 | 62,377,750.72 | 286,150,196.66 | 196,528,634.32 | 129,890,811.56 | 55,015,035.24 |
研发费用(元) | 207,277,477.75 | 149,426,599.51 | 58,997,464.13 | 220,464,212.85 | 139,290,606.86 | 90,908,954.12 | 44,378,770.68 |
营业税金及附加(元) | 16,947,394.51 | 11,349,759.91 | 5,320,831.72 | 21,859,833.51 | 16,447,129.17 | 10,615,533.85 | 4,845,148.34 |
销售费用(元) | 299,221,885.06 | 191,144,478.32 | 86,103,841.50 | 397,514,521.13 | 293,892,286.59 | 173,741,583.34 | 76,261,361.48 |
管理费用(元) | 166,310,583.93 | 109,948,872.63 | 59,663,725.44 | 250,278,441.47 | 176,169,771.62 | 109,763,326.79 | 50,688,639.26 |
财务费用(元) | -40,193,825.75 | -27,222,084.50 | -14,649,437.08 | -72,343,891.92 | -57,815,269.59 | -40,662,242.31 | -18,769,658.90 |
其中:利息费用(元) | 643,979.17 | 442,940.01 | 225,274.41 | 1,418,072.57 | 750,794.40 | 509,822.43 | 259,464.39 |
其中:利息收入(元) | 41,015,216.17 | 27,281,549.39 | 14,967,931.00 | 71,787,417.75 | 57,072,634.34 | 39,594,369.47 | 19,711,758.91 |
三、其他经营收益 | |||||||
加:公允价值变动收益(元) | -15,935,793.60 | -10,938,482.40 | 4,547,164.17 | 8,102,948.80 | 5,373,742.01 | 5,231,449.39 | 5,836,919.33 |
加:投资收益(元) | 14,609,762.67 | 8,228,475.14 | 2,821,281.49 | 25,022,730.62 | 22,391,909.76 | 13,009,174.06 | 3,408,793.25 |
其中:对联营企业和合营企业的投资收益(元) | -6,374,166.62 | -2,050,534.16 | -1,279,023.09 | -7,212,165.78 | 614,760.38 | 140,351.88 | 1,546,964.09 |
资产处置收益(元) | 90,854.59 | 90,854.59 | 43,073.13 | 2,482,317.43 | 33,624.83 | 8,811.65 | - |
资产减值损失(元) | -26,455,350.80 | -20,060,706.72 | -10,711,140.75 | -109,805,229.70 | -45,159,991.88 | -13,943,068.39 | -3,683,354.04 |
信用减值损失(元) | -11,138,182.19 | -9,894,892.82 | -1,457,802.36 | -13,088,976.99 | -14,181,866.08 | -10,470,420.60 | -717,529.12 |
其他收益(元) | 15,240,836.32 | 11,541,396.88 | 5,884,211.90 | 18,901,991.16 | 14,575,643.92 | 10,031,379.91 | 4,847,873.73 |
四、营业利润(元) | 406,987,821.51 | 273,721,769.85 | 108,021,869.52 | 577,795,555.86 | 553,213,975.37 | 400,918,281.04 | 150,795,939.21 |
加:营业外收入(元) | 111,700.00 | 109,700.00 | 1,000.00 | 1,539,545.60 | 54,000.00 | 50,000.00 | - |
减:营业外支出(元) | 1,937,324.57 | 1,676,764.60 | 55,822.19 | 2,955,337.88 | 1,213,887.59 | 477,970.25 | 133,382.96 |
五、利润总额(元) | 405,162,196.94 | 272,154,705.25 | 107,967,047.33 | 576,379,763.58 | 552,054,087.78 | 400,490,310.79 | 150,662,556.25 |
减:所得税费用(元) | 75,464,068.90 | 51,941,395.28 | 26,503,346.24 | 110,456,196.90 | 88,536,526.90 | 66,878,783.01 | 23,619,661.58 |
六、净利润(元) | 329,698,128.04 | 220,213,309.97 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 | 127,042,894.67 |
(一)按经营持续性分类 | |||||||
持续经营净利润(元) | 329,698,128.04 | 220,213,309.97 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 | 127,042,894.67 |
(二)按所有权归属分类 | |||||||
归属于母公司股东的净利润(元) | 329,698,128.04 | 220,213,309.97 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 | 127,042,894.67 |
扣除非经常性损益后的净利润(元) | 311,957,559.89 | 210,689,910.14 | 68,349,710.89 | 412,509,493.25 | 427,870,804.64 | 309,210,884.55 | 116,031,504.20 |
七、每股收益 | |||||||
一、基本每股收益(元) | 0.80 | 0.53 | 0.20 | 1.12 | 1.11 | 0.80 | 0.31 |
二、稀释每股收益(元) | 0.80 | 0.53 | 0.20 | 1.12 | 1.11 | 0.80 | 0.31 |
九、综合收益总额(元) | 329,698,128.04 | 220,213,309.97 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 | 127,042,894.67 |
归属于母公司所有者的综合收益总额(元) | 329,698,128.04 | 220,213,309.97 | 81,463,701.09 | 465,923,566.68 | 463,517,560.88 | 333,611,527.78 | 127,042,894.67 |
公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-30 | 2024-04-23 | 2023-10-27 | 2023-08-30 | 2023-04-28 |
审计意见(境内) | 标准无保留意见 | ||||||
原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
上市前/上市后 |
报表类型 |
一、营业总收入(元) |
营业收入(元) |
二、营业总成本(元) |
营业成本(元) |
研发费用(元) |
营业税金及附加(元) |
销售费用(元) |
管理费用(元) |
财务费用(元) |
其中:利息费用(元) |
其中:利息收入(元) |
三、其他经营收益 |
加:公允价值变动收益(元) |
加:投资收益(元) |
其中:对联营企业和合营企业的投资收益(元) |
资产处置收益(元) |
资产减值损失(元) |
信用减值损失(元) |
其他收益(元) |
四、营业利润(元) |
加:营业外收入(元) |
减:营业外支出(元) |
五、利润总额(元) |
减:所得税费用(元) |
六、净利润(元) |
(一)按经营持续性分类 |
持续经营净利润(元) |
(二)按所有权归属分类 |
归属于母公司股东的净利润(元) |
扣除非经常性损益后的净利润(元) |
七、每股收益 |
一、基本每股收益(元) |
二、稀释每股收益(元) |
九、综合收益总额(元) |
归属于母公司所有者的综合收益总额(元) |
公告日期 |
审计意见(境内) |
原始财报文件下载 |
Showing 1 to 40 of 40 entries